EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Variations in Neuroinflammatory Chemokine Receptor Genes in Patients with Epilepsy: An Exploratory Study

Kubra Cigdem Pekkoc-Uyanik iD, Erhan Rasit Agay iD, Hafize Uzun iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Kubra Cigdem Pekkoc-Uyanik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Haliç University, 34060 Istanbul, Turkey. Hauptthemen laut MEDLINE: Epilepsy, Receptors, CCR5, Receptors, CXCR4, Polymorphism, Single Nucleotide. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is a common neurological disorder in which genetic and neuroinflammatory mechanisms may contribute to differences in seizure control. Chemokine receptor signaling plays an important role in inflammatory processes, and genetic variations in neuroinflammatory chemokine receptor genes may potentially influence the prognosis of epilepsy. This study aimed to investigate genetic variations in the neuroinflammatory chemokine receptor genes CCR5 and CXCR4 in patients with epilepsy and to explore their potential association with seizure control during treatment. Targeted next-generation sequencing (tNGS) was performed to investigate genetic variations in the CCR5 and CXCR4 genes using genomic DNA obtained from 22 patients with epilepsy receiving antiseizure medication (ASM) treatment with levetiracetam and/or valproic acid. Patients were classified into two groups according to seizure frequency to evaluate the association between genetic variation and clinical prognosis. A total of seven genetic variants were identified in the CCR5 and CXCR4 genes, including three variants in CCR5 and four variants in CXCR4. However, sufficient genotype variation for group-wise comparisons was available only for CCR5 rs1799988 and rs1800023. No significant differences were observed in the genotype or allele distributions of the CCR5 and CXCR4 gene variants between the responsive and persistent groups. The two CCR5 variants, rs1799988 and rs1800023, showed strong linkage disequilibrium (D′ = 1.000, r2 = 0.913) and were included in a single haplotype block. None of the identified CCR5 haplotypes was significantly associated with seizure control. In this preliminary cohort, no statistically significant associations were detected between the analyzed genetic variations and seizure control during treatment; however, the limited sample size may have reduced the statistical power to detect potential associations. Strong linkage disequilibrium was observed between rs1799988 and rs1800023 (D′ = 1.000, r2 = 0.913), consistent with previously reported patterns. Given the small sample size and the limited number of informative variants, these findings should be interpreted as preliminary and hypothesis-generating rather than as evidence for or against a genetic contribution to seizure control. Larger, independent cohorts are needed to assess the potential clinical relevance of CCR5 and CXCR4 variation in epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyReceptors, CCR5Receptors, CXCR4Polymorphism, Single NucleotideHumansFemaleMaleLinkage DisequilibriumAdultAdolescentGenetic VariationYoung AdultGenotypeGenetic Predisposition to DiseaseGene FrequencyChildHaplotypes

Stichwörter der Autor:innen

CCR5CXCR4gene sequencinghaplotype analysislinkage disequilibriumpolymorphism

Substanzen

Receptors, CCR5Receptors, CXCR4CCR5 protein, humanCXCR4 protein, human

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Haliç University, 34060 Istanbul, Turkey.
  • Sinan Sipahi Family Health Centre, Republic of Turkey Ministry of Health, 34295 Istanbul, Turkey.
  • Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey.

ORCID-Profile: Kubra Cigdem Pekkoc-Uyanik, Erhan Rasit Agay, Hafize Uzun

Zitieren

APA

Pekkoc-Uyanik, K. C., Agay, E. R., & Uzun, H. (2026). Genetic Variations in Neuroinflammatory Chemokine Receptor Genes in Patients with Epilepsy: An Exploratory Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219471

Vancouver

Pekkoc-Uyanik KC, Agay ER, Uzun H. Genetic Variations in Neuroinflammatory Chemokine Receptor Genes in Patients with Epilepsy: An Exploratory Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219471

BibTeX
@article{PekkocUyanik2026,
  author = {Pekkoc-Uyanik, Kubra Cigdem and Agay, Erhan Rasit and Uzun, Hafize},
  title = {Genetic Variations in Neuroinflammatory Chemokine Receptor Genes in Patients with Epilepsy: An Exploratory Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219471}
}
Kostenlos starten →